Please enable Javascript on your browser for a better experience.
The Lymphocyte Subset Panel 1 measures key immune cell types, including natural killer cells (CD16+CD56), B cells (CD19), and T cells (CD3, CD4, CD8), with both percentages and absolute counts. It also calculates the helper/suppressor (CD4/CD8) ratio. This test helps evaluate immune system function, monitor immune deficiencies, autoimmune diseases, infections, and response to treatment.
The White Blood Cell Count with Differential Test measures total white blood cells and breaks them into types, including neutrophils, lymphocytes, monocytes, eosinophils, and basophils. Doctors order this test to evaluate infections, inflammation, immune disorders, and blood cancers. Abnormal results may suggest bacterial or viral infections, allergies, or leukemia. Results provide key insight into immune system health, disease detection, and treatment monitoring.
The Beta-2-Microglobulin (B2M) Test measures levels of B2M, a protein found on most cell surfaces and released into the blood. Elevated levels may indicate multiple myeloma, lymphoma, chronic infections, or kidney disease. Doctors order this test to evaluate cancer stage, prognosis, or kidney function. Results provide essential insight into disease progression, immune activity, and treatment monitoring for blood cancers and renal disorders.
The IgG Subclasses Panel measures four IgG antibody subclasses (IgG1, IgG2, IgG3, IgG4) to assess immune system function. Abnormal levels may indicate primary immunodeficiency, recurrent infections, autoimmune disease, or allergic conditions. Doctors order this test for patients with chronic sinus, lung, or ear infections or suspected immune imbalance. Results provide key insight into antibody response, guiding diagnosis, treatment, and long-term immune monitoring.
The Kappa/Lambda Light Chains, Free with Ratio Blood Test measures free kappa and lambda light chains, proteins produced by plasma cells, and calculates their ratio. Abnormal results may indicate multiple myeloma, light chain amyloidosis, or related plasma cell disorders. Doctors use this test with serum protein electrophoresis and immunofixation to detect, diagnose, and monitor disease progression or treatment response in patients with suspected blood cancers.
The Epstein-Barr Virus (EBV) Nuclear Antigen (EBNA) IgG Antibody Test detects IgG antibodies that usually appear after acute infection, confirming past exposure or infection recovery. Doctors order this test alongside VCA and EA antibodies to determine the stage of EBV infection. Results help distinguish recent versus past EBV, guide diagnosis of mononucleosis, and support evaluation of chronic fatigue or EBV-related health conditions.
The Cytomegalovirus (CMV) IgG IgM Antibodies Test detects both recent and past infection with CMV, a common herpesvirus. IgM indicates recent or active infection, while IgG shows past exposure and possible immunity. Doctors order this test for pregnant women, immunocompromised patients, or those with unexplained fever or fatigue. Results help diagnose CMV, guide treatment, and assess risk of complications such as congenital infection or organ damage.
The Epstein-Barr Virus Antibody (EBV) Panel detects antibodies to EBV, including VCA IgM, VCA IgG, and EBNA IgG, to determine current, recent, or past infection. EBV causes infectious mononucleosis and has links to chronic fatigue and certain cancers. Doctors order this test for patients with fever, sore throat, swollen lymph nodes, or fatigue. Results help identify stage of infection, confirm diagnosis, and guide clinical management of EBV-related illness.
The HLA (Human Leukocyte Antigen) Typing for Celiac Disease test is a genetic test that identifies specific HLA gene variants associated with an increased risk of developing celiac disease. Celiac disease is an autoimmune disorder triggered by the ingestion of gluten, a protein found in wheat, barley, and rye. This test aids in assessing the genetic predisposition to celiac disease.
